Skip to Main Content

Author Details

Stephanie S Yee
University of Pennsylvania
2010
36
17
PMIDPaper TitleJournal TitlePublished Year
36689092Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.Breast Cancer Res Treat2023
36322403Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma.Oncotarget2022
35811459Transcriptional profiling of single tumour cells from pleural effusions reveals heterogeneity of epithelial to mesenchymal transition and extra-cellular matrix marker expression.Clin Transl Med2022
35939771Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma.JCO Precis Oncol2022
33067248THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement.Cancer Prev Res (Phila)2021
33615225Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma.Neurooncol Adv2021
34733417THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma.Oncotarget2021
34454115Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis.J Mol Diagn2021
34095713Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy.JCO Precis Oncol2021
33976268Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors.Sci Rep2021
32140683Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma.Neurooncol Adv2020
31666247Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.Clin Cancer Res2020
32102950Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.Clin Cancer Res2020
32299821A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma.Clin Cancer Res2020
30325992Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.JAMA Oncol2019
31489121Correction: Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue.Oncotarget2019
31217895Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue.Oncotarget2019
30842658Hepatocytes direct the formation of a pro-metastatic niche in the liver.Nature2019
30642547Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients.Lung Cancer2019
28786531Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma.Pigment Cell Melanoma Res2018
30549400An integrated enrichment system to facilitate isolation and molecular characterization of single cancer cells from whole blood.Cytometry A2018
29568081An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters.Sci Rep2018
29735554miRNA Profiling of Magnetic Nanopore-Isolated Extracellular Vesicles for the Diagnosis of Pancreatic Cancer.Cancer Res2018
28653249Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.Breast Cancer Res Treat2017
28500398Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.Breast Cancer Res Treat2017
29019651Combining Machine Learning and Nanofluidic Technology To Diagnose Pancreatic Cancer Using Exosomes.ACS Nano2017
28809985A magnetic micropore chip for rapid (<1 hour) unbiased circulating tumor cell isolation and in situ RNA analysis.Lab Chip2017
28819852Enumeration, Dielectrophoretic Capture, and Molecular Analysis of Circulating Tumor Cells.Methods Mol Biol2017
27468416A novel approach for next-generation sequencing of circulating tumor cells.Mol Genet Genomic Med2016
27601595Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA.Clin Cancer Res2016
24634144Comprehensive analysis of gene expression in human retina and supporting tissues.Hum Mol Genet2014
23098370Matrix metalloproteinases and educational attainment in refractive error: evidence of gene-environment interactions in the Age-Related Eye Disease Study.Ophthalmology2013
24227913Regional replication of association with refractive error on 15q14 and 15q25 in the Age-Related Eye Disease Study cohort.Mol Vis2013
23498719Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.Lancet Oncol2013
21859326Acute biological effects of simulating the whole-body radiation dose distribution from a solar particle event using a porcine model.Radiat Res2011
20235421Lack of compliance with national vaccination guidelines in oncology patients receiving radiation therapy.J Support Oncol2010
  • 1 - 36 of 36

Recommended Authors

Personal Genome Diagnostics Inc.
Career Start Year 2016
Number of shared co-authors 0
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Roche Sequencing Solutions Inc.
Career Start Year 2011
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 1
University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Brigham and Women's Hospital, USA Harvard Medical School
Career Start Year 2006
Number of shared co-authors 1
Tokyo Medical and Dental University Hospital
Career Start Year 2006
Number of shared co-authors 0
University of California San Diego Moores Cancer Center
Career Start Year 2006
Number of shared co-authors 1
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 1
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 0
Michelson Center for Convergent Bioscience, University of Southern California
Career Start Year 2004
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 3
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2000
Number of shared co-authors 1
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 3
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 1
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 1
H. Lee Moffitt Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
Career Start Year 1996
Number of shared co-authors 0
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 0
Stanford University
Career Start Year 1994
Number of shared co-authors 0
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 0
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0

Collaborators

Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Guardant Health Inc.
Co-authored papers 2
Co-authored papers 2
Indiana University School of Medicine
Co-authored papers 1
Co-authored papers 1
Nanfang Hospital and Basic Medical College, Southern Medical University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
INSERM U1245
Co-authored papers 1
Cancer Center Amsterdam
Co-authored papers 1
Toronto Western Hospital
Co-authored papers 1
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 1
Co-authored papers 1
and Informatics Perelman School of Medicine, University of Pennsylvania
Co-authored papers 1
University of Alberta
Co-authored papers 1
Co-authored papers 1
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers 1
Abramson Cancer Center, University of Pennsylvania
Co-authored papers 1
Toronto Western Hospital
Co-authored papers 1
Ontario Cancer Institute/Princess Margaret Hospital, University Health Network
Co-authored papers 1
Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine
Co-authored papers 1
VU University Medical Center
Co-authored papers 1
The Eye Cancer Clinic, Princess Margaret Cancer Centre, Hospital for Sick Children
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Co-authored papers 1
Mayo Clinic
Co-authored papers 1